NCT05076981View on ClinicalTrials.gov

Progesterone Levels During Ovulation and Luteal Phase

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Infertility, Female
Interventions
DRUG

human chorionic gonadotropin

once the dominant follicle reaches 17mm or above, a bolus of 6500 rhCG (Ovitrelle, Merck-Serono) will be administered subcutaneously

Trial Locations (1)

60202

ART Fertility Clinics LLC, Abu Dhabi

All Listed Sponsors
lead

ART Fertility Clinics LLC

OTHER

NCT05076981 - Progesterone Levels During Ovulation and Luteal Phase | Biotech Hunter | Biotech Hunter